Plan of Reorganization Agreements in the Biotechnology Industry
26 Contracts & Agreements
- AbbVie Inc. (2 contracts)
- Allarity Therapeutics, Inc. (1)
- ARROWHEAD PHARMACEUTICALS, INC. (1)
- ATOSSA GENETICS INC (1)
- BIO-PATH HOLDINGS INC (2)
- BioRestorative Therapies, Inc. (1)
- Capstone Therapeutics Corp. (1)
- ImmunoCellular Therapeutics, Ltd. (3)
- InMed Pharmaceuticals Inc. (4)
- MANHATTAN SCIENTIFICS INC (1)
- MeiraGTx Holdings plc (1)
- NEUROBIOLOGICAL TECHNOLOGIES INC (1)
- Ohr Pharmaceutical Inc (1)
- Organicell Regenerative Medicine, Inc. (1)
- POLARITYTE, INC. (2)
- Progenics Pharmaceuticals, Inc. (1)
- vTv Therapeutics Inc. (2)
- Amended and Restated Plan of Reorganization and Asset Purchase Agreement by and among Allarity Therapeutics, Inc. a Delaware corporation, Allarity Acquisition Subsidiary, a... (Allarity Therapeutics, Inc., Filed With SEC on December 6, 2021)
- Amended and Restated Agreement and Plan of Reorganization, dated as of October 13, 2021, by and among InMed Pharmaceuticals Inc., BayMedica, LLC, BayMedica, Inc., BM REP, LLC, as... (InMed Pharmaceuticals Inc., Filed With SEC on October 13, 2021)
- Form of Series B Warrant (to be issued pursuant to the Agreement and Plan of Reorganization, dated as of September 10, 2021, by and among InMed Pharmaceuticals Inc., InMed LLC,... (InMed Pharmaceuticals Inc., Filed With SEC on September 24, 2021)
- Form of Series A Warrant (to be issued pursuant to the Agreement and Plan of Reorganization, dated as of September 10, 2021, by and among InMed Pharmaceuticals Inc., InMed LLC,... (InMed Pharmaceuticals Inc., Filed With SEC on September 24, 2021)
- Agreement and Plan of Reorganization, dated as of September 10, 2021, by and among InMed Pharmaceuticals Inc., InMed LLC, BayMedica, Inc., BM REP, LLC, as the stockholder... (InMed Pharmaceuticals Inc., Filed With SEC on September 24, 2021)
- PLAN SUPPLEMENT TO AMENDED JOINT PLAN OF REORGANIZATION OF BIORESTORATIVE THERAPIES, INC. AND AUCTUS FUND, LLC (BioRestorative Therapies, Inc., Filed With SEC on November 5, 2020)
- Form of Shareholder Agreement (to be effective upon consummation of the Corporate Reorganization) (MeiraGTx Holdings plc, Filed With SEC on June 4, 2018)
- Plan and Agreement of Reorganization, dated April 23, 2018, between Management and Business Associates, LLC and Biotech Products Services and Research, Inc (Organicell Regenerative Medicine, Inc., Filed With SEC on April 26, 2018)
- FIRST AMENDMENT TO AGREEMENT AND PLAN OF REORGANIZATION (POLARITYTE, INC., Filed With SEC on December 16, 2016)
- AGREEMENT AND PLAN OF REORGANIZATION (POLARITYTE, INC., Filed With SEC on December 7, 2016)
- REORGANIZATION AGREEMENT Dated as of July 29, 2015 (vTv Therapeutics Inc., Filed With SEC on August 4, 2015)
- REORGANIZATION AGREEMENT Dated as of [_________] 2015 (vTv Therapeutics Inc., Filed With SEC on July 23, 2015)
- AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF REORGANIZATION (AbbVie Inc., Filed With SEC on March 23, 2015)
- AGREEMENT AND PLAN OF REORGANIZATION by and among ABBVIE INC., OXFORD AMHERST CORPORATION, OXFORD AMHERST LLC and PHARMACYCLICS, INC. dated as of March 4, 2015 (AbbVie Inc., Filed With SEC on March 6, 2015)
- AGREEMENT AND PLAN OF REORGANIZATION BY AND AMONG ATOSSA GENETICS INC., ACUEITY HEALTHCARE, INC. AND TED LACHOWICZ, AS THE STOCKHOLDER REPRESENTATIVE (for the limited purposes... (ATOSSA GENETICS INC, Filed With SEC on October 4, 2012)
- AGREEMENT AND PLAN OF REORGANIZATION (MANHATTAN SCIENTIFICS INC, Filed With SEC on June 6, 2011)
- MERGERAGREEMENT AND PLAN OF REORGANIZATION (Ohr Pharmaceutical Inc, Filed With SEC on August 11, 2009)
- AGREEMENT AND PLAN OFREORGANIZATION by and between INSERT THERAPEUTICS, INC. and (ARROWHEAD PHARMACEUTICALS, INC., Filed With SEC on January 18, 2008)
- Agreement and Plan of Reorganization (BIO-PATH HOLDINGS INC, Filed With SEC on September 27, 2007)
- Agreement and Plan of Reorganization (BIO-PATH HOLDINGS INC, Filed With SEC on November 30, 2006)
- AGREEMENT AND PLAN OF REORGANIZATION (ImmunoCellular Therapeutics, Ltd., Filed With SEC on January 26, 2006)
- AGREEMENT AND PLAN OF REORGANIZATION (ImmunoCellular Therapeutics, Ltd., Filed With SEC on January 26, 2006)
- AGREEMENT AND PLAN OF REORGANIZATION (ImmunoCellular Therapeutics, Ltd., Filed With SEC on January 26, 2006)
- AGREEMENT AND PLAN OF REORGANIZATION by and among PROGENICS PHARMACEUTICALS, INC., PROGENICS PHARMACEUTICALS NEVADA, INC. UR LABS, INC. and SHAREHOLDERS OF UR LABS, INC. Dated as... (Progenics Pharmaceuticals, Inc., Filed With SEC on December 28, 2005)
- AMENDMENT NO. 2 TO ASSET PURCHASE AGREEMENT AND PLAN OF REORGANIZATION (Capstone Therapeutics Corp., Filed With SEC on August 6, 2004)
- AGREEMENT AND PLAN OF REORGANIZATION by and among NEUROBIOLOGICAL TECHNOLOGIES, INC. (NEUROBIOLOGICAL TECHNOLOGIES INC, Filed With SEC on July 15, 2004)